Evidence map›Paper›PMID 35406766›Full record

ArticleCells2022

The Inhibitory Effect of Selected D

Natalia Kasica, Anna Święch, Katarzyna Saładziak, Jerzy Mackiewicz, Maciej Osęka

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Dopamine D2 Receptor Agonists as Modulators of VEGF-A-Driven Angiogenesis: Mechanisms, Clinical Evidence, and Translational Opportunities.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  2. Review
  3. Article
  4. [Advances in pharmacological research for retinopathy of prematurity].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2025
    Review
  5. Review
  6. Review
  7. Article
  8. Retinal Toxicity Induced by Chemical Agents.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Natalia KasicaDepartment of Animal Anatomy, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Oczapowskiego 13 Street, Box 105J, 10-719 Olsztyn, Poland.ORCID 0000-0002-0242-2587
Anna ŚwięchDepartment of Retina and Vitreus Surgery, Medical University in Lublin, Chmielna 1 Street, 20-079 Lublin, Poland.
Katarzyna SaładziakDepartment of Retina and Vitreus Surgery, Medical University in Lublin, Chmielna 1 Street, 20-079 Lublin, Poland.
Jerzy MackiewiczDepartment of Retina and Vitreus Surgery, Medical University in Lublin, Chmielna 1 Street, 20-079 Lublin, Poland.
Maciej OsękaOftalabs Sp. z o.o., Wrocławska 130, 58-306 Wałbrzych, Poland.ORCID 0000-0002-8017-3432
Medical University of Lublin · PLUniversity of Warmia and Mazury in Olsztyn · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathological angiogenesis is correlated with many ophthalmic diseases. The most common are exudative age-related macular degeneration and proliferative diabetic retinopathy. The current treatment for these diseases is based on regularly administered anti-VEGF antibodies injections. In the study, we investigated selected D

Indexed as

Dopamine AgonistsZebrafishAngiogenesis InhibitorsAnimalsBevacizumabBromocriptineCabergolineHypoxiaLarvaNeovascularization, PathologicPergolideVascular Endothelial Growth Factor AAngiogenesis InhibitorsBevacizumabBromocriptineCabergolineDopamine AgonistsPergolideVascular Endothelial Growth Factor AangiogenesisbromocriptinecabergolineD2 dopaminergic receptor agonisthyaloid-retinal vessels (HRVs)intersegmental vessels (ISVs)pergolidevascular endothelial growth factorzebrafish

Identifiers

PMID35406766
PMCPMC8997652
OpenAlexW4223496704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.